These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 8239247)

  • 1. Infectious morbidity associated with long-term use of venous access devices in patients with cancer.
    Groeger JS; Lucas AB; Thaler HT; Friedlander-Klar H; Brown AE; Kiehn TE; Armstrong D
    Ann Intern Med; 1993 Dec; 119(12):1168-74. PubMed ID: 8239247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term, totally implantable central venous access ports connected to a Groshong catheter for chemotherapy of solid tumours: experience from 178 cases using a single type of device.
    Biffi R; Corrado F; de Braud F; de Lucia F; Scarpa D; Testori A; Orsi F; Bellomi M; Mauri S; Aapro M; Andreoni B
    Eur J Cancer; 1997 Jul; 33(8):1190-4. PubMed ID: 9301441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Totally implantable central venous access ports for long-term chemotherapy. A prospective study analyzing complications and costs of 333 devices with a minimum follow-up of 180 days.
    Biffi R; de Braud F; Orsi F; Pozzi S; Mauri S; Goldhirsch A; Nolè F; Andreoni B
    Ann Oncol; 1998 Jul; 9(7):767-73. PubMed ID: 9739444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guidelines for the management of intravascular catheter-related infections.
    Mermel LA; Farr BM; Sherertz RJ; Raad II; O'Grady N; Harris JS; Craven DE;
    J Intraven Nurs; 2001; 24(3):180-205. PubMed ID: 11530364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implantable venous port-related infections in cancer patients.
    Huang WT; Chen TY; Su WC; Yen CJ; Tsao CJ
    Support Care Cancer; 2004 Mar; 12(3):197-201. PubMed ID: 14727170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Infectious and non-infectious complications of tunneled central catheters in hematologic patients].
    Albo López C; López Rodríguez D; Constenla Camba MI; Jimenéz Blanco A; Araujo LF; García-Medina J
    Sangre (Barc); 1999 Jun; 44(3):176-81. PubMed ID: 10481577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of device-associated infections related to a long-term implantable vascular access device.
    Sotir MJ; Lewis C; Bisher EW; Ray SM; Soucie JM; Blumberg HM
    Infect Control Hosp Epidemiol; 1999 Mar; 20(3):187-91. PubMed ID: 10100545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective, randomized evaluation of the effect of silver impregnated subcutaneous cuffs for preventing tunneled chronic venous access catheter infections in cancer patients.
    Groeger JS; Lucas AB; Coit D; LaQuaglia M; Brown AE; Turnbull A; Exelby P
    Ann Surg; 1993 Aug; 218(2):206-10. PubMed ID: 8343002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hickman catheters in association with intensive cancer chemotherapy.
    Newman KA; Reed WP; Schimpff SC; Bustamante CI; Wade JC
    Support Care Cancer; 1993 Mar; 1(2):92-7. PubMed ID: 8143107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experience with 100 consecutive central venous access arm ports placed by interventional radiologists.
    Hills JR; Cardella JF; Cardella K; Waybill PN
    J Vasc Interv Radiol; 1997; 8(6):983-9. PubMed ID: 9399467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study of infectious complications of different types of chronic central venous access devices.
    Keung YK; Watkins K; Chen SC; Groshen S; Silberman H; Douer D
    Cancer; 1994 Jun; 73(11):2832-7. PubMed ID: 7864923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complications of indwelling venous access devices in patients with gynecologic malignancies.
    Estes JM; Rocconi R; Straughn JM; Bhoola S; Leath CA; Alvarez RD; Kilgore LC; Huh WK
    Gynecol Oncol; 2003 Dec; 91(3):591-5. PubMed ID: 14675682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The late complications of totally implantable central venous access ports: the results from an Italian multicenter prospective observation study.
    Dal Molin A; Rasero L; Guerretta L; Perfetti E; Clerico M
    Eur J Oncol Nurs; 2011 Dec; 15(5):377-81. PubMed ID: 21167777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of infections and complications in central venous catheters in adults with solid tumours.
    Coady K; Ali M; Sidloff D; Kenningham RR; Ahmed S
    J Vasc Access; 2015; 16(1):38-41. PubMed ID: 25198809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of totally implanted reservoirs with external catheters as venous access devices in pediatric oncologic patients.
    Ross MN; Haase GM; Poole MA; Burrington JD; Odom LF
    Surg Gynecol Obstet; 1988 Aug; 167(2):141-4. PubMed ID: 3400032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subcutaneously implanted central venous access devices in cancer patients: a prospective analysis.
    Schwarz RE; Groeger JS; Coit DG
    Cancer; 1997 Apr; 79(8):1635-40. PubMed ID: 9118051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Totally implantable venous access ports: frequency of complications and analysis of bacterial contamination after ablation].
    Barbut F; Soukouna S; Lalande V; Garcia ML; Neyme D; de Gramont A; Petit JC
    Pathol Biol (Paris); 2004 Dec; 52(10):566-74. PubMed ID: 15596304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The duration of functioning of a subcutaneous implantable port for the treatment of hematological tumors: a single institution-based study.
    Ohno H; Mizumoto C; Otsuki Y; Oguma S; Yoshida Y
    Int J Clin Oncol; 2010 Apr; 15(2):172-8. PubMed ID: 20195680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infectious complications of implantable ports and Hickman catheters in paediatric haematology-oncology patients.
    Adler A; Yaniv I; Steinberg R; Solter E; Samra Z; Stein J; Levy I
    J Hosp Infect; 2006 Mar; 62(3):358-65. PubMed ID: 16377030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous bacterial colonization, modalities of chemotherapeutic infusion, and catheter-related bloodstream infection in totally implanted venous access devices.
    Laurenzi L; Natoli S; Benedetti C; Marcelli ME; Tirelli W; DiEmidio L; Arcuri E
    Support Care Cancer; 2004 Nov; 12(11):805-9. PubMed ID: 15372220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.